Report Detail
Global Benztropine Mesylate Market Insights, Forecast to 2025
- RnM3498615 |
- 06 June, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Benzatropine, also known as benztropine, is an anticholinergic marketed under the trade name Cogentin which is used in the treatment of Parkinson's disease, Parkinsonism, and dystonia.
The global Benztropine Mesylate market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Benztropine Mesylate market based on company, product type, end user and key regions.
This report studies the global market size of Benztropine Mesylate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Benztropine Mesylate in these regions.
This research report categorizes the global Benztropine Mesylate market by top players/brands, region, type and end user. This report also studies the global Benztropine Mesylate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Akorn
Zydus Pharmaceuticals
ANI Pharmaceuticals
PLIVA
Fresenius Kabi
Hikma Pharmaceuticals
Cipla
Navinta
Aspen Pharmacare
Market size by Product
Injection
Oral
Market size by End User
Parkinsonism
Extrapyramidal symptoms
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Benztropine Mesylate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Benztropine Mesylate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Benztropine Mesylate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Benztropine Mesylate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Benztropine Mesylate are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Benztropine Mesylate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Benztropine Mesylate Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Benztropine Mesylate Market Size Growth Rate by Product
- 1.4.2 Injection
- 1.4.3 Oral
- 1.5 Market by End User
- 1.5.1 Global Benztropine Mesylate Market Size Growth Rate by End User
- 1.5.2 Parkinsonism
- 1.5.3 Extrapyramidal symptoms
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Benztropine Mesylate Market Size
- 2.1.1 Global Benztropine Mesylate Revenue 2014-2025
- 2.1.2 Global Benztropine Mesylate Sales 2014-2025
- 2.2 Benztropine Mesylate Growth Rate by Regions
- 2.2.1 Global Benztropine Mesylate Sales by Regions
- 2.2.2 Global Benztropine Mesylate Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Benztropine Mesylate Sales by Manufacturers
- 3.1.1 Benztropine Mesylate Sales by Manufacturers
- 3.1.2 Benztropine Mesylate Sales Market Share by Manufacturers
- 3.1.3 Global Benztropine Mesylate Market Concentration Ratio (CR5 and HHI)
- 3.2 Benztropine Mesylate Revenue by Manufacturers
- 3.2.1 Benztropine Mesylate Revenue by Manufacturers (2014-2019)
- 3.2.2 Benztropine Mesylate Revenue Share by Manufacturers (2014-2019)
- 3.3 Benztropine Mesylate Price by Manufacturers
- 3.4 Benztropine Mesylate Manufacturing Base Distribution, Product Types
- 3.4.1 Benztropine Mesylate Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Benztropine Mesylate Product Type
- 3.4.3 Date of International Manufacturers Enter into Benztropine Mesylate Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Benztropine Mesylate Sales by Product
- 4.2 Global Benztropine Mesylate Revenue by Product
- 4.3 Benztropine Mesylate Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Benztropine Mesylate Breakdown Data by End User
6 North America
- 6.1 North America Benztropine Mesylate by Countries
- 6.1.1 North America Benztropine Mesylate Sales by Countries
- 6.1.2 North America Benztropine Mesylate Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Benztropine Mesylate by Product
- 6.3 North America Benztropine Mesylate by End User
7 Europe
- 7.1 Europe Benztropine Mesylate by Countries
- 7.1.1 Europe Benztropine Mesylate Sales by Countries
- 7.1.2 Europe Benztropine Mesylate Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Benztropine Mesylate by Product
- 7.3 Europe Benztropine Mesylate by End User
8 Asia Pacific
- 8.1 Asia Pacific Benztropine Mesylate by Countries
- 8.1.1 Asia Pacific Benztropine Mesylate Sales by Countries
- 8.1.2 Asia Pacific Benztropine Mesylate Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Benztropine Mesylate by Product
- 8.3 Asia Pacific Benztropine Mesylate by End User
9 Central & South America
- 9.1 Central & South America Benztropine Mesylate by Countries
- 9.1.1 Central & South America Benztropine Mesylate Sales by Countries
- 9.1.2 Central & South America Benztropine Mesylate Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Benztropine Mesylate by Product
- 9.3 Central & South America Benztropine Mesylate by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Benztropine Mesylate by Countries
- 10.1.1 Middle East and Africa Benztropine Mesylate Sales by Countries
- 10.1.2 Middle East and Africa Benztropine Mesylate Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Benztropine Mesylate by Product
- 10.3 Middle East and Africa Benztropine Mesylate by End User
11 Company Profiles
- 11.1 Akorn
- 11.1.1 Akorn Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Akorn Benztropine Mesylate Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Akorn Benztropine Mesylate Products Offered
- 11.1.5 Akorn Recent Development
- 11.2 Zydus Pharmaceuticals
- 11.2.1 Zydus Pharmaceuticals Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Zydus Pharmaceuticals Benztropine Mesylate Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Zydus Pharmaceuticals Benztropine Mesylate Products Offered
- 11.2.5 Zydus Pharmaceuticals Recent Development
- 11.3 ANI Pharmaceuticals
- 11.3.1 ANI Pharmaceuticals Company Details
- 11.3.2 Company Business Overview
- 11.3.3 ANI Pharmaceuticals Benztropine Mesylate Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 ANI Pharmaceuticals Benztropine Mesylate Products Offered
- 11.3.5 ANI Pharmaceuticals Recent Development
- 11.4 PLIVA
- 11.4.1 PLIVA Company Details
- 11.4.2 Company Business Overview
- 11.4.3 PLIVA Benztropine Mesylate Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 PLIVA Benztropine Mesylate Products Offered
- 11.4.5 PLIVA Recent Development
- 11.5 Fresenius Kabi
- 11.5.1 Fresenius Kabi Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Fresenius Kabi Benztropine Mesylate Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Fresenius Kabi Benztropine Mesylate Products Offered
- 11.5.5 Fresenius Kabi Recent Development
- 11.6 Hikma Pharmaceuticals
- 11.6.1 Hikma Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Hikma Pharmaceuticals Benztropine Mesylate Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Hikma Pharmaceuticals Benztropine Mesylate Products Offered
- 11.6.5 Hikma Pharmaceuticals Recent Development
- 11.7 Cipla
- 11.7.1 Cipla Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Cipla Benztropine Mesylate Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Cipla Benztropine Mesylate Products Offered
- 11.7.5 Cipla Recent Development
- 11.8 Navinta
- 11.8.1 Navinta Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Navinta Benztropine Mesylate Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Navinta Benztropine Mesylate Products Offered
- 11.8.5 Navinta Recent Development
- 11.9 Aspen Pharmacare
- 11.9.1 Aspen Pharmacare Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Aspen Pharmacare Benztropine Mesylate Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Aspen Pharmacare Benztropine Mesylate Products Offered
- 11.9.5 Aspen Pharmacare Recent Development
12 Future Forecast
- 12.1 Benztropine Mesylate Market Forecast by Regions
- 12.1.1 Global Benztropine Mesylate Sales Forecast by Regions 2019-2025
- 12.1.2 Global Benztropine Mesylate Revenue Forecast by Regions 2019-2025
- 12.2 Benztropine Mesylate Market Forecast by Product
- 12.2.1 Global Benztropine Mesylate Sales Forecast by Product 2019-2025
- 12.2.2 Global Benztropine Mesylate Revenue Forecast by Product 2019-2025
- 12.3 Benztropine Mesylate Market Forecast by End User
- 12.4 North America Benztropine Mesylate Forecast
- 12.5 Europe Benztropine Mesylate Forecast
- 12.6 Asia Pacific Benztropine Mesylate Forecast
- 12.7 Central & South America Benztropine Mesylate Forecast
- 12.8 Middle East and Africa Benztropine Mesylate Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Benztropine Mesylate Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Benztropine Mesylate . Industry analysis & Market Report on Benztropine Mesylate is a syndicated market report, published as Global Benztropine Mesylate Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Benztropine Mesylate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
